Biotechnology
OpenAI’s GPT-Rosalind is a large language model tuned on common biology workflows and public databases, built to suggest pathways and prioritise drug targets. Citing bioweapon risk, OpenAI is limiting access to vetted US-based researchers for now.
WHY THIS MATTERS IN BRIEF Life runs on ATP – the energy molecules of all living things – and now…
WHY THIS MATTERS IN BRIEF What’s the worst that could happen if you could trick a researcher into fabricating a…
WHY THIS MATTERS IN BRIEF Once oil wells are tapped out they’re capped, but now they’re getting a new lease…
WHY THIS MATTERS IN BRIEF This is the second time we’ve created a superbug, and it shows how powerful gene…
WHY THIS MATTERS IN BRIEF Life’s DNA has always been coded using just four letters, but now researchers have added…
WHY THIS MATTERS IN BRIEF This could cause a conundrum – is lab made meat considered vegan? From an…
WHY THIS MATTERS IN BRIEF Noone will be sad to see the back of animal testing. Before a new…